Alzheimer's disease and blood-based biomarkers – potential contexts of use

Alzheimer's disease and blood-based biomarkers – potential contexts of use

Martina Zvěřová1,2 1Department of Psychiatry, General University Hospital in Prague, Prague, Czech Republic; 2First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Abstract: Alzheimer’s disease (AD) is an irreversible, incurable, progressive neurodege...

Full description

Bibliographic Details
Main Author: Zvěřová M
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
biomarker
Alzheimer's disease
neurodegeneration
cerebrospinal fluid
beta amyloid
tau protein
Online Access:https://www.dovepress.com/alzheimers-disease-and-blood-based-biomarkers-potential-contexts-of-us-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/alzheimers-disease-and-blood-based-biomarkers-potential-contexts-of-us-peer-reviewed-article-NDT

Similar Items